JP2005500366A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500366A5
JP2005500366A5 JP2003518522A JP2003518522A JP2005500366A5 JP 2005500366 A5 JP2005500366 A5 JP 2005500366A5 JP 2003518522 A JP2003518522 A JP 2003518522A JP 2003518522 A JP2003518522 A JP 2003518522A JP 2005500366 A5 JP2005500366 A5 JP 2005500366A5
Authority
JP
Japan
Prior art keywords
substituent
hydrocarbon group
aliphatic hydrocarbon
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003518522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500366A (ja
JP5137289B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/024487 external-priority patent/WO2003013513A1/en
Publication of JP2005500366A publication Critical patent/JP2005500366A/ja
Publication of JP2005500366A5 publication Critical patent/JP2005500366A5/ja
Application granted granted Critical
Publication of JP5137289B2 publication Critical patent/JP5137289B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003518522A 2001-08-03 2001-08-03 安定な乳化組成物 Expired - Fee Related JP5137289B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/024487 WO2003013513A1 (en) 2001-08-03 2001-08-03 Stable emulsion composition

Publications (3)

Publication Number Publication Date
JP2005500366A JP2005500366A (ja) 2005-01-06
JP2005500366A5 true JP2005500366A5 (enExample) 2008-09-18
JP5137289B2 JP5137289B2 (ja) 2013-02-06

Family

ID=21742754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003518522A Expired - Fee Related JP5137289B2 (ja) 2001-08-03 2001-08-03 安定な乳化組成物

Country Status (5)

Country Link
US (1) US7960416B2 (enExample)
EP (1) EP1420783A4 (enExample)
JP (1) JP5137289B2 (enExample)
CA (1) CA2456029C (enExample)
WO (1) WO2003013513A1 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US7416756B2 (en) 2003-09-10 2008-08-26 Eastman Chemical Company Process for the recovery of a phytolipid composition
US20050239745A1 (en) * 2004-03-03 2005-10-27 Ophthalmic Research Associates, Inc. Novel topical ophthalmic formulations
WO2006063048A2 (en) 2004-12-06 2006-06-15 Avigen, Inc. Ibudilast for treating neuropathic pain and associated syndromes
MY147790A (en) 2005-04-28 2013-01-31 Takeda Pharmaceutical Stable emulsion composition
US8187659B2 (en) * 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
JPWO2007132825A1 (ja) * 2006-05-15 2009-09-24 武田薬品工業株式会社 医薬
US20070275053A1 (en) * 2006-05-26 2007-11-29 Luise Anneliese Lenk Anti-stick formula delivered by spray process to facilitate swallowing of solid object, such as pill, tablet capsule or caplet.
RU2470644C2 (ru) * 2006-09-05 2012-12-27 Кью.Пи. КОПЭРЕЙШН Стабильная жировая эмульсия (варианты), способ ее получения, эмульгирующий агент и способы стабилизации простагландина и капель жира
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PL2131841T3 (pl) * 2007-01-30 2013-03-29 Avigen Inc Sposoby leczenia bólu ostrego
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
US20080287402A1 (en) * 2007-05-03 2008-11-20 Johnson Kirk W Use of a glial attenuator to prevent amplified pain responses caused by glial priming
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
RU2418601C2 (ru) * 2007-10-10 2011-05-20 Закрытое акционерное общество "Эвалар" Средство, обладающее гепатопротекторным, детоксицирующим и регенерирующим действием
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
SG10201503402XA (en) 2010-01-27 2015-06-29 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
AU2011340797B2 (en) * 2010-12-10 2017-08-10 Ns Technologies Pty Ltd Methods for forming miniemulsions and use thereof for delivering bioactive agents
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
AU2016267568A1 (en) * 2015-05-28 2017-10-12 The Regents Of The University Of Colorado, A Body Corporate Methods of preventing and treating autoimmunity
CA3018727C (en) 2016-03-24 2024-03-26 The Regents Of The University Of Colorado, A Body Corporate Methods of treating autoimmune disease
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2844756B2 (ja) * 1989-12-01 1999-01-06 日本新薬株式会社 脂肪乳剤
JPH04173736A (ja) * 1990-11-06 1992-06-22 Nippon Shinyaku Co Ltd 乳化剤
CA2095627C (en) 1990-11-06 1999-01-05 Junzo Seki Stable lyophilized fatty emulsions and a process for the production thereof
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CA2182698A1 (en) 1994-02-25 1995-08-31 Jun Sato Injectable emulsions containing antifungal triazole derivatives
JPH0827018A (ja) * 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
DK1063228T5 (da) * 1998-03-09 2009-06-15 Takeda Pharmaceutical Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
CN1416341B (zh) * 2000-02-04 2010-05-05 武田药品工业株式会社 稳定的乳液组合物
JP4863553B2 (ja) * 2000-02-04 2012-01-25 武田薬品工業株式会社 安定な乳化組成物

Similar Documents

Publication Publication Date Title
RU2309951C2 (ru) Производные никотинамида, способы их получения, фармацевтическая композиция на их основе и применение
WO2003080580A3 (en) Quinoline derivatives and their use as 5-ht6 ligands
JP2022533398A5 (enExample)
TWI374196B (en) Method of forming dielectric films, new precursors and their use in the semi-conductor manufacturing
KR910009660A (ko) 새로운 이소인돌론 유도체 및 이의 제조 방법
RU2000127751A (ru) Противоопухолевое средство
JP2011511073A5 (enExample)
CA2407149A1 (en) Melanin-concentrating hormone antagonist
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
RU98119523A (ru) Соединения пиперазина и пиперидина
AU4306796A (en) Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
CA2679232A1 (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
KR920009796A (ko) 3-아미도인돌릴 유도체
RU2003117476A (ru) Аминотиазолы и их применение в качестве антагонистов рецептора аденозина
RU2020102453A (ru) Фармацевтические композиции
RU2003105900A (ru) Производные 4,5-дигидро-1h-пиразола, обладающие cb1-антагонистической активностью
JP2010535722A5 (enExample)
KR880013888A (ko) 신규 디티오아세탈 화합물, 그의 제조방법 및 이 화합물로 되는 제약 조성물
DE60318583D1 (de) N-äphenyl(piperidin-2-yl)methylübenzamid-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
RU2000125568A (ru) Производные циклоалкенов, их получение и применение
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
JP2019500315A5 (enExample)
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
WO2009007536A3 (fr) Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique
RU92016234A (ru) Производные 3(2н)-пиридазинона, способ их получения, применение, фармацевтическая композиция, способ лечения